← Open Payments lookup

OCIER BLANCO: Open Payments

NPI 1912661364 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,200 in 116 payments from 14 companies in 2025. Trend: 2023 $1,015 · 2024 $1,659 · 2025 $2,200

Food & beverage: $2,200
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$345
Otsuka America Pharmaceutical, Inc.13$271
Neurocrine BioSciences, Inc.11$230
Janssen Pharmaceuticals, Inc15$221
Teva Pharmaceuticals USA, Inc.14$220
Takeda Pharmaceuticals U.S.A., Inc.8$201
Alkermes, Inc.11$189
Vanda Pharmaceuticals Inc.11$136
Lundbeck LLC5$129
E.R. Squibb & Sons, L.L.C.5$114

Products named: CAPLYTA, REXULTI, INGREZZA, TRINTELLIX, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR, COBENFY.

Industry payments across FL — which companies pay providers there.